Classes
Publications
- Alirocumab, Praluent(R) in the light of studies2016 | First Faculty of Medicine
- Metabolic syndrome - new approaches2011 | First Faculty of Medicine
- Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children2011 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Metabolism +12010 | First Faculty of Medicine
- Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndrome2009 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Pravastatin and its place in therapy of dyslipidemia in 20102009 | First Faculty of Medicine
- Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...